Table 1. Demographic data and treatment features.
Demographic data (n = 299) | ||
---|---|---|
Median age | 31, 45 years | 18–47 years |
Median BMI | 24 | 17.4–77.6 |
Nulliparous (data available only for 184 patients) | 148 | 79% |
Hysteroscopic resection prior to medical treatment | 4 studies, 76 patients | 25% |
Pharmacological agents I. Megestrol Acetate II. MPA III. LNG-IUD IV. Letrozole/Anastrozole V. GnRH-a (Leuprolide) VI. Combined Oral Contraceptives VII. Lynestrenol VIII. Tamoxifen (always in association with other drugs) IX. Norethisterone acetate X. Hydroxyprogesterone caproate |
18 studies 14 studies 5 studies 1 study 2 studies 1 study 1 study 2 studies 2 studies 1 study |
|
Median duration of therapy | 6 months | 2–49 months |